Beloranib Completed Phase 1 Trials for Obesity Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01028261Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers
NCT01372761Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers
NCT01507077ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity